What are the recommended intravenous fluconazole dosing regimens and clinical indications for adults, children, and neonates?

IV Fluconazole Dosing and Indications

For adults with invasive candidiasis, start with an 800 mg (12 mg/kg) loading dose followed by 400 mg (6 mg/kg) daily; for neonates with disseminated candidiasis, use 12 mg/kg IV daily as a reasonable alternative to amphotericin B if not on fluconazole prophylaxis. 1

Adult Dosing by Indication

Invasive Candidiasis (Candidemia, Disseminated Disease)

• Loading dose: 800 mg (12 mg/kg) on day 1
• Maintenance: 400 mg (6 mg/kg) daily 1, 2
• Duration: Minimum 2 weeks after blood culture clearance and symptom resolution
• Note: This applies to non-neutropenic ICU patients in settings with >5% invasive candidiasis rates (weak recommendation) 1

Oropharyngeal Candidiasis

• Loading dose: 200 mg on day 1
• Maintenance: 100 mg daily 2
• Duration: Minimum 2 weeks to prevent relapse

Esophageal Candidiasis

• Loading dose: 200 mg on day 1
• Maintenance: 100 mg daily (up to 400 mg daily based on response) 2
• Duration: Minimum 3 weeks and at least 2 weeks after symptom resolution

Cryptococcal Meningitis

• Acute treatment: 400 mg daily (may use 400 mg on day 1 as loading dose) 2
• Duration: 10-12 weeks after CSF culture negativity
• Suppressive therapy (AIDS patients): 200 mg daily 2

Urinary Tract Infections and Peritonitis

• Dose: 50-200 mg daily 2
• Note: Based on limited open-label studies

Prophylaxis in Bone Marrow Transplant

• Dose: 400 mg daily 2
• Timing: Start several days before anticipated neutropenia (<500 cells/mm³), continue for 7 days after neutrophil count >1000 cells/mm³

---

Pediatric Dosing (≥6 months old)

Oropharyngeal Candidiasis

• Loading dose: 6 mg/kg on day 1
• Maintenance: 3 mg/kg daily 2
• Duration: Minimum 2 weeks

Esophageal Candidiasis

• Loading dose: 6 mg/kg on day 1
• Maintenance: 3 mg/kg daily (up to 12 mg/kg daily based on response) 2
• Duration: Minimum 3 weeks and at least 2 weeks after symptom resolution

Systemic Candida Infections (≥3 months old)

• Loading dose: 25 mg/kg on day 1 (max 800 mg)
• Maintenance: 12 mg/kg daily (max 400 mg) 2
• Duration: Minimum 3 weeks and at least 2 weeks after symptom resolution

Cryptococcal Meningitis

• Acute treatment: 12 mg/kg on day 1, then 6 mg/kg daily (may use 12 mg/kg daily based on response) 2
• Duration: 10-12 weeks after CSF culture negativity
• Suppressive therapy (AIDS patients): 6 mg/kg daily 2

---

Neonatal Dosing (Birth to 3 months)

Disseminated Candidiasis

For neonates ≥30 weeks gestational age:

• Loading dose: 25 mg/kg on day 1
• Maintenance: 12 mg/kg daily 1, 2

For neonates <30 weeks gestational age:

• Loading dose: 25 mg/kg on day 1
• Maintenance: 9 mg/kg daily 2

Critical timing considerations for very young neonates (based on postnatal age):

• First 2 weeks of life: Administer dose every 72 hours 3
• Weeks 2-4 of life: Administer dose every 48 hours 3
• After 4 weeks: Daily dosing appropriate 3

This age-adjusted dosing reflects the prolonged elimination half-life and increased volume of distribution in the first month of life 3.

Prophylaxis in High-Risk Neonates

• Dose: 3-6 mg/kg twice weekly (IV or oral) 4
• Target population: Neonates <1000 g in NICUs with high IC incidence (>12%) (A-I recommendation) 4
• Lower incidence NICUs (<2%): Use case-by-case with risk stratification (central lines, third-generation cephalosporins/carbapenems) (B-II recommendation) 4
• Efficacy: 91% reduction in invasive candidiasis 4

---

Special Populations

Renal Impairment

After initial loading dose (50-400 mg based on indication):

• CrCl >50 mL/min: 100% of standard dose
• CrCl ≤50 mL/min (no dialysis): 50% of standard dose
• Hemodialysis: 100% of dose after each dialysis session 2

Pediatric Patients on ECMO

For patients ≥3 months:

• Loading dose: 35 mg/kg on day 1 (max 800 mg)
• Maintenance: 12 mg/kg daily (max 400 mg) 2

For neonates <3 months, ≥30 weeks gestational age:

• Loading dose: 35 mg/kg on day 1
• Maintenance: 12 mg/kg daily 2

For neonates <3 months, <30 weeks gestational age:

• Loading dose: 35 mg/kg on day 1
• Maintenance: 9 mg/kg daily 2

Critically Ill Adults on CVVHD

Recent evidence suggests standard dosing is insufficient. Start with at least 400 mg twice daily to achieve therapeutic targets in patients on continuous veno-venous hemodialysis 5.

---

Administration Guidelines

• Maximum infusion rate: 200 mg/hour as continuous infusion 2
• Route: IV only for these formulations; oral bioavailability is excellent when IV not required
• Therapeutic drug monitoring: Target trough concentrations 4-20 mcg/mL in neonates 3; target AUC₀₋₂₄ >400 mg·h/L for invasive infections 6, 7

---

Critical Clinical Pearls

Loading doses are essential: A 25 mg/kg loading dose in infants achieves therapeutic targets (AUC >400 mg·h/L) on day 1 in 63% of patients versus delayed achievement with standard dosing 7. This matters for mortality reduction.

Neonatal dosing is not simply weight-based: Serum creatinine and postnatal age dramatically affect clearance. Recent pharmacokinetic modeling shows clearance increases 16% per 100 g body weight increase and decreases 12% per 10 µmol/L creatinine increase after 1 week of age 6. Monitor creatinine and adjust accordingly.

The 2016 IDSA guidelines prioritize fluconazole for neonates as a strong recommendation (moderate-quality evidence) when not on prophylaxis, positioning it as equivalent to amphotericin B deoxycholate 1. This reflects both efficacy and superior safety profile.

Common pitfall: Using maintenance dosing without a loading dose in critically ill patients delays therapeutic target attainment and may worsen outcomes. Always use loading doses for invasive infections 7.

Resistance considerations: Fluconazole prophylaxis in NICUs has not led to emergence of resistant Candida species even after 8-10 years of use 4, but empiric use should be avoided in patients with known fluconazole-resistant organisms or recent fluconazole exposure.